Literature DB >> 28658821

Intracorneal Amphotericin B Injection in a Case of Indolent Candidal Keratitis.

Jyoti Deswal1, Sudesh Kumar Arya2.   

Abstract

Ocular candidiasis is one of the opportunistic infection occurring in human body. Pathogenesis wise, Candida is very virulent and slow growing organism. We report a case of 76-year-old female with left eye candidal stromal abscess, not responding to topical and oral antifungal drugs. Patient was administered intrastromal amphotericin B injection in the affected eye. Four midstromal injections were given in the areas surrounding the corneal abscess. A total of approximately 0.05 mL of amphotericin B, 5 μg per 0.1 mL, was administered. Within next four weeks, the eye became completely quiet with healed epithelial defect and corneal scarring. Intracorneal injection of amphotericin B is a safe and effective treatment option for recurrent and recalcitrant fungal infections.

Entities:  

Keywords:  Abscess; Candida; Intrastromal; Photophobia

Year:  2017        PMID: 28658821      PMCID: PMC5483723          DOI: 10.7860/JCDR/2017/23249.9774

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  An evaluation of intrastromal injection of antifungal agents.

Authors:  D M O'Day; W S Head; R D Robinson; T E Williams
Journal:  J Ocul Pharmacol       Date:  1991

2.  Candida keratitis: emerging problem in India.

Authors:  Jayangshu Sengupta; Archana Khetan; Suman Saha; Debdulal Banerjee; Nibaran Gangopadhyay; Dipanjan Pal
Journal:  Cornea       Date:  2012-04       Impact factor: 2.651

3.  [Homologous antilymphocyte antibodies synthesized by limbocorneal lymphoid foci during the delayed hypersensitivyt phase. Analysis of the limbal immunologic reaction after intracorneal injection of homospecific spleen homogenate].

Authors:  C Claudio; G Gino
Journal:  Riv Anat Patol Oncol       Date:  1968

4.  Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.

Authors:  Namrata Sharma; Prakashchand Agarwal; Rajesh Sinha; Jeewan S Titiyal; Thirumurthy Velpandian; Rasik B Vajpayee
Journal:  Br J Ophthalmol       Date:  2011-03-31       Impact factor: 4.638

5.  Toxicity and pharmacokinetics of intrastromal injection of amphotericin B in a rabbit model.

Authors:  Linghui Qu; Liangmao Li; Hanping Xie
Journal:  Curr Eye Res       Date:  2013-11-11       Impact factor: 2.424

6.  Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.

Authors:  Namrata Sharma; Jacob Chacko; Thirumurthy Velpandian; Jeewan S Titiyal; Rajesh Sinha; Gita Satpathy; Radhika Tandon; Rasik B Vajpayee
Journal:  Ophthalmology       Date:  2012-12-12       Impact factor: 12.079

7.  Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.

Authors:  Linghui Qu; Liangmao Li; Hanping Xie
Journal:  Ophthalmic Res       Date:  2009-11-04       Impact factor: 2.892

8.  Intracameral amphotericin B injection in the management of deep keratomycosis.

Authors:  Thomas Kuriakose; Mihir Kothari; Padma Paul; Pushpa Jacob; Ravi Thomas
Journal:  Cornea       Date:  2002-10       Impact factor: 2.651

9.  Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India.

Authors:  Bibhudutta Rautaraya; Savitri Sharma; Sarita Kar; Sujata Das; Srikant K Sahu
Journal:  BMC Ophthalmol       Date:  2011-12-22       Impact factor: 2.209

Review 10.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

View more
  1 in total

1.  Collagen-binding peptides for the enhanced imaging, lubrication and regeneration of osteoarthritic articular cartilage.

Authors:  Chin-Yu Lin; Yung-Li Wang; Yu-Jen Chen; Chun-Te Ho; Yi-Hsuan Chi; Long Yi Chan; Guan-Wen Chen; Horng-Chaung Hsu; Dennis W Hwang; Han-Chung Wu; Shih-Chieh Hung
Journal:  Nat Biomed Eng       Date:  2022-10-13       Impact factor: 29.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.